New and emerging treatments for schizophrenia: a narrative review of their pharmacology, efficacy and side effect profile relative to established antipsychotics. (2022)
Attributed to:
MICA: Targeting neuro-inflammation in Schizophrenia
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.neubiorev.2021.11.032
PubMed Identifier: 34838528
Publication URI: http://europepmc.org/abstract/MED/34838528
Type: Journal Article/Review
Volume: 132
Parent Publication: Neuroscience and biobehavioral reviews
ISSN: 0149-7634